SCHEMBL6472099

SCHEMBL6472099

COCCn1c(-c2csc(-c3ccc(C)nc3)n2)cc(C(=O)NCCC2=CCCCC2)c1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
RAB9A P51151 8/20 0.39
NPC1 O15118 7/20 0.39
SMN1; SMN2 Q16637 6/20 0.39
HPGD P15428 4/20 0.39
MAPT P10636 3/20 0.39
ALOX15 P16050 2/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
ATM Q13315 1/20 0.39
HSD17B10 Q99714 1/20 0.39
THRB P10828 1/20 0.39
NLRP3 Q96P20 1/20 0.39
KDM4E B2RXH2 3/20 0.39
MEN1 O00255 2/20 0.39
GAA P10253 2/20 0.39
KMT2A Q03164 2/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5043427 0.81 GSK3B (0.44) ALDH1A1HPGDMAPTHTTMEN1
SCHEMBL5043694 0.80 EIF4E (0.41) ALDH1A1RAB9ANPC1SMN1; SMN2MAPT
SCHEMBL5047149 0.76 ALDH1A1 (0.42) ALDH1A1RAB9ANPC1SMN1; SMN2HPGD
SCHEMBL5048621 0.74 KLKB1 (0.48) ALDH1A1RAB9ANPC1SMN1; SMN2HPGD
SCHEMBL5048681 0.73 ALDH1A1 (0.61) ALDH1A1L3MBTL1RAB9ANPC1SMN1; SMN2
SCHEMBL5043697 0.73 IDH1 (0.45) ALDH1A1SMN1; SMN2HPGDMEN1KMT2A
SCHEMBL5044978 0.72 KLKB1 (0.49) ALDH1A1RAB9ANPC1SMN1; SMN2HPGD
SCHEMBL5039558 0.72 SREBF2 (0.39) ALDH1A1L3MBTL1
SCHEMBL5043787 0.71 ALDH1A1 (0.51) ALDH1A1L3MBTL1RAB9ANPC1SMN1; SMN2
SCHEMBL5046987 0.71 KLKB1 (0.48) ALDH1A1RAB9ANPC1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583762-A1 PYRROLYL-THIAZOLES AND THEIR USE AS CB 1 RECEPTOR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2005-10-12 EP disclosed
WO-2004060888-A1 NOVEL CB 1 RECEPTOR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2004-07-22 WO disclosed